Patient characteristics
. | IFM 99-03 . | IFM 99-04 . | P . |
|---|---|---|---|
| No. patients | 65 | 219 | |
| Age at diagnosis, y, median (range) | 54 (36-65) | 58 (28-65) | .006 |
| No. men/no. women | 32/33 | 114/105 | .79 |
| Isotype, no. | .64 | ||
| G | 35 | 121 | |
| A | 21 | 62 | |
| BJ | 9 | 36 | |
| Stage, no. | .85 | ||
| 1 | 1 | 2 | |
| 2 | 10 | 24 | |
| 3 | 54 | 193 | |
| β2-microglobulin level, mg/L, median (range) | 4.1 (3.1-16.6) | 4.9 (3.03-39.4) | .049 |
| Albumin level, g/L, median (range) | 38 (27-52) | 38 (16.2-54) | .47 |
| Platelet count, 109 g/L, median (range) | 220 (45-346) | 211 (20-500) | .65 |
| Hemoglobin level, g/dL, median (range) | 9.8 (5.2-13.5) | 9.8 (4.7-14.7) | .82 |
| Calcium level, mmol/L, median (range) | 2.4 (1.8-3.97) | 2.43 (1.87-4.5) | .41 |
| CRP level, mg/L, median (range) | 5 (1-132) | 6 (1-279) | .48 |
. | IFM 99-03 . | IFM 99-04 . | P . |
|---|---|---|---|
| No. patients | 65 | 219 | |
| Age at diagnosis, y, median (range) | 54 (36-65) | 58 (28-65) | .006 |
| No. men/no. women | 32/33 | 114/105 | .79 |
| Isotype, no. | .64 | ||
| G | 35 | 121 | |
| A | 21 | 62 | |
| BJ | 9 | 36 | |
| Stage, no. | .85 | ||
| 1 | 1 | 2 | |
| 2 | 10 | 24 | |
| 3 | 54 | 193 | |
| β2-microglobulin level, mg/L, median (range) | 4.1 (3.1-16.6) | 4.9 (3.03-39.4) | .049 |
| Albumin level, g/L, median (range) | 38 (27-52) | 38 (16.2-54) | .47 |
| Platelet count, 109 g/L, median (range) | 220 (45-346) | 211 (20-500) | .65 |
| Hemoglobin level, g/dL, median (range) | 9.8 (5.2-13.5) | 9.8 (4.7-14.7) | .82 |
| Calcium level, mmol/L, median (range) | 2.4 (1.8-3.97) | 2.43 (1.87-4.5) | .41 |
| CRP level, mg/L, median (range) | 5 (1-132) | 6 (1-279) | .48 |